Ibis Prepares Next-Gen Microorganism Detector For Diagnostic Space
This article was originally published in The Gray Sheet
Executive Summary
Five years ago the U.S. Department of Defense commissioned California-based Isis Pharmaceuticals to develop a new technology to more easily detect bioterrorism agents. Now, $55.6 million in government grants later, the company is readying the Ibis T5000 Biosensor System to make its way into the in vitro diagnostics space
You may also be interested in...
Abbott Grabs Ibis’ T5000 Biosensor System For Infectious Disease Diagnostics
Abbott will focus on developing molecular diagnostics for hospital-acquired infections using Ibis Biosciences' T5000 biosensor system after acquiring the business for $215 million
Abbott Grabs Ibis’ T5000 Biosensor System For Infectious Disease Diagnostics
Abbott will focus on developing molecular diagnostics for hospital-acquired infections using Ibis Biosciences' T5000 biosensor system after acquiring the business for $215 million
Siemens, Other Top Dx Firms Wax Molecular At AACC Lab Conference
Siemens bought its way to the top of the in vitro diagnostics market during the past two years and is now aiming to make gains in one of the fastest growing segments of that sector - molecular diagnostics